Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials 33
Prominent Drugs 35
Clinical Trial Profile Snapshots 37
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 80
Contact Us 81
Source 81

List of Tables
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2018* 17
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2018* 21
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Phase, 2018* 24
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 30
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List of Figures
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2018* 16
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2018* 20
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 30
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
GlobalData Methodology 80

Companies Mentioned
- CSL Ltd
- Octapharma AG
- Shire Plc
- Ministry of Health France
- Creat Group Corp
- Archemix Corp
- Grifols SA
- Pfizer Inc
- Baxter International Inc
- Ferring Holding SA